Simplex Trading, LLC Allakos Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 95,673 shares of ALLK stock, worth $101,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,673

Previous 501 18996.41%

Holding current value

$101,413

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$0.54 - $0.92 $51,392 - $87,558	95,172 Added 18996.41%	95,673 $62,000
Q2 2024 Jul 25, 2024	SELL	$1.0 - $1.45 $15,458 - $22,414	-15,458 Reduced 96.86%	501 $0
Q1 2024 Apr 25, 2024	SELL	$1.02 - $3.23 $8,289 - $26,250	-8,127 Reduced 33.74%	15,959 $20,000
Q4 2023 Feb 02, 2024	BUY	$1.72 - $3.18 $41,427 - $76,593	24,086 New	24,086 $65,000
Q1 2023 Apr 27, 2023	BUY	$4.3 - $8.27 $16,051 - $30,871	3,733 Added 794.26%	4,203 $18,000
Q4 2022 Feb 02, 2023	SELL	$5.66 - $8.42 $466,531 - $694,026	-82,426 Reduced 99.43%	470 $3,000
Q3 2022 Nov 04, 2022	SELL	$3.02 - $6.12 $23,284 - $47,185	-7,710 Reduced 8.51%	82,896 $507,000
Q2 2022 Aug 03, 2022	BUY	$2.6 - $6.14 $231,514 - $546,730	89,044 Added 5700.64%	90,606 $283,000
Q1 2022 May 02, 2022	SELL	$5.08 - $9.81 $72,405 - $139,821	-14,253 Reduced 90.12%	1,562 $8,000
Q4 2021 Feb 23, 2022	BUY	$8.55 - $111.89 $110,808 - $1.45 Million	12,960 Added 453.94%	15,815 $154,000
Q3 2021 Oct 28, 2021	BUY	$76.53 - $110.43 $15,306 - $22,086	200 Added 7.53%	2,855 $249,000
Q2 2021 Aug 12, 2021	SELL	$85.37 - $114.1 $175,862 - $235,046	-2,060 Reduced 43.69%	2,655 $226,000
Q1 2021 Apr 26, 2021	BUY	$109.73 - $153.66 $517,376 - $724,506	4,715 New	4,715 $541,000
Q4 2020 Feb 02, 2021	SELL	$79.58 - $152.45 $21,327 - $40,856	-268 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$66.43 - $90.99 $9,300 - $12,738	-140 Reduced 34.31%	268 $21,000
Q2 2020 Jul 13, 2020	SELL	$44.04 - $80.69 $9,336 - $17,106	-212 Reduced 34.19%	408 $29,000
Q1 2020 Apr 29, 2020	BUY	$44.49 - $93.39 $27,583 - $57,901	620 New	620 $27,000
Q4 2019 Feb 05, 2020	SELL	$66.49 - $137.73 $23,537 - $48,756	-354 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$31.0 - $89.73 $10,974 - $31,764	354 New	354 $27,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Allakos Inc. Transaction History